OOIR: Observatory of International Research

Papers

(The H4-Index of Gut Pathogens is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)

Article	Citations
Gut microbiota influence in type 2 diabetes mellitus (T2DM)	113
Designing a novel multi-epitope vaccine to evoke a robust immune response against pathogenic multidrug-resistant Enterococcus faecium bacterium	66
Eubacterium rectale contributes to colorectal cancer initiation via promoting colitis	64
Mechanisms and microbial influences on CTLA-4 and PD-1-based immunotherapy in the treatment of cancer: a narrative review	48
In silico molecular docking and in vitro antimicrobial efficacy of phytochemicals against multi-drug-resistant enteroaggregative Escherichia coli and non-typhoidal Salmonella spp.	40
The use of biomarkers associated with leaky gut as a diagnostic tool for early intervention in autism spectrum disorder: a systematic review	37
Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?	33
Plasmid mediated colistin resistant mcr-1 and co-existence of OXA-48 among Escherichia coli from clinical and poultry isolates: first report from Nepal	32
Association of small intestinal bacterial overgrowth with Parkinson’s disease: a systematic review and meta-analysis	32
Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections	31
Ectopic gut colonization: a metagenomic study of the oral and gut microbiome in Crohn’s disease	30
Emergence of plasmid-mediated mcr genes from Gram-negative bacteria at the human-animal interface	27
Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors	26
Genome sequences of two clinical Escherichia coli isolates harboring the novel colistin-resistance gene variants mcr-1.26 and mcr-1.27	26
Fusobacterium nucleatum infection correlates with two types of microsatellite alterations in colorectal cancer and triggers DNA damage	23
Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients	22
The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease	22
Potential role of intestinal microflora in disease progression among patients with different stages of Hepatitis B	22
Prevalence, antimicrobial resistance, and genotyping of Shiga toxin-producing Escherichia coli in foods of cattle origin, diarrheic cattle, and diarrheic humans in Egypt	20
Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial	20
Antimicrobial resistance patterns and genetic elements associated with the antibiotic resistance of Helicobacter pylori strains from Shanghai	20
Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B	20